10/8/24 - 10/12/24 : 29th Annual Congress of the World Muscle Society 2024 Congress

SRPT 10.08.2024

Full Press ReleaseSEC FilingsOur SRPT Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2024 Net Product Revenue
  • 01.13.2025 - 1/13/2512:00 PM EST : Sarepta Therapeutics at the 43rd Annual J.P. Morgan Healthcare Conference Presentation and Q&A
  • 01.06.2025 - Sarepta Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.13.2025 - 8-K Current report
  • 12.30.2024 - 4 Statement of changes in beneficial ownership of securities

«Back

29th Annual Congress of the World Muscle Society 2024 Congress

10/08 - 10/12/24

Supporting Materials

P.391 Madeco et al. LOA Definitions in DMD332.5 KB
P.94 Lowes et al. JOURNEY natural history study250.1 KB
P.423 Mendell et al. EMBARK primary results427.1 KB
P.424 Proud et al. ENDEAVOR Phase 1b347.5 KB
P. 425 Mendell et al. Study 101 five-year Follow-up298 KB
P.428 Walter et al. EMBARK Cardiac MRI323.2 KB

Location

Prague, Czechia

This section of our website may contain dated or archived information which should not be considered current and may no longer be accurate. For current information, you are encouraged to review our most recent official corporate documents on file with the U.S. Securities and Exchange Commission.

This website, including releases and presentations posted on it, contains "forward-looking statements." Any statements that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “believe,” “anticipate,” “plan,” “expect,” “will,” “may,” “intend,” “prepare,” “look,” “potential,” “possible” and similar expressions are intended to identify forward-looking statements. These forward‐looking statements involve risks and uncertainties, many of which are beyond our control and are based on our current beliefs, expectations and assumptions regarding our business. Actual results and financial condition could materially differ from those stated or implied by these forward‐looking statements as a result of such risks and uncertainties and could materially and adversely affect our business, results of operations and trading price. Potential known risk factors include those risks identified under the heading “Risk Factors” in Sarepta’s most recent Annual Report on Form 10-K and most recent Quarterly Report on Form 10‐Q filed with the Securities and Exchange Commission (SEC) and in its other SEC filings.

For a detailed and updated description of risks and uncertainties Sarepta faces, you are encouraged to review Sarepta's filings with the SEC. We caution investors not to place considerable reliance on the forward‐looking statements contained in this website. Other than as required under applicable law, Sarepta does not undertake any obligation to publicly update its forward‐looking statements.


Toolkit

Print Page|Email Alerts|RSS Feeds|Contacts

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com